Schuster Laurentia, Sielker Sonja, Kleinheinz Johannes, Dammaschke Till
Department of Periodontology and Operative Dentistry, University of Münster, Münster, Germany.
Clinic for Oral and Maxillofacial Surgery, University Hospital Münster, Münster, Germany.
Int Endod J. 2025 Jul;58(7):1060-1072. doi: 10.1111/iej.14242. Epub 2025 Apr 25.
Gold standard as material in vital pulp therapy (VPT) is hydraulic calcium silicate cements (HCSC). To circumvent their prolonged setting time, light-cured pulp capping materials containing calcium silicate or calcium hydroxide powder are available. Although their positive biological properties are advertised, the data regarding the biocompatibility of light-cured pulp capping materials (LCPCM) is inconclusive. This in vitro study compared the biocompatibility of five LCPCM containing calcium silicate (TheraCal LC, ReviCal, MTA PulpCap, Pulprotec MTA) or calcium hydroxide (Calcimol LC) with that of the HCSC Biodentine.
Of each material, 226 cylindrical specimens (51.472 mm) were prepared and incubated in a sterile cell culture medium (alpha Modified Eagle Medium) for 24 h to obtain an extract. Human dental pulp cells (hDPC) were added to the specimens and/or extracts. Cell viability and changes in cell morphology were examined (MTT, LDH, live-dead staining, light microscope). Calcium release from the materials (Ca colorimetric assay) and the mineralisation capacity of the cells (Alizarin Red S Staining, Alkaline Phosphatase Assay) were determined. Statistical analysis was performed by anova and the post-hoc Tukey test (p < 0.05).
Compared to Biodentine, hDPC showed significantly lower cell viability when in contact with LCPCM (p < 0.05). Further, an inhibition zone around the test bodies or an altered cell morphology was observed. Biodentine showed almost no negative effects on cell viability or cell morphology. In contact with Biodentine, hDPC mineralise with and without mineralisation induction conditions. Among the LCPCM, mineralisation was only detectable under induction conditions with ReViCal and MTA PulpCap. In addition, Biodentine released significantly more calcium ions than the LCPCM (p < 0.05).
In this in vitro study, LCPCM showed cytotoxic effects on hDPC and were hardly able to induce cell mineralisation. Biodentine showed little negative effects on cell viability, induced cell mineralisation and released more calcium than LCPCM. Biodentine is significantly superior to LCPCM in terms of biocompatibility and mineralisation induction capacity.
用于牙髓活力治疗(VPT)的金标准材料是水硬性硅酸钙水泥(HCSC)。为了克服其较长的凝固时间,有含硅酸钙或氢氧化钙粉末的光固化牙髓盖髓材料可供使用。尽管它们宣称具有积极的生物学特性,但关于光固化牙髓盖髓材料(LCPCM)生物相容性的数据尚无定论。这项体外研究比较了五种含硅酸钙(TheraCal LC、ReviCal、MTA PulpCap、Pulprotec MTA)或氢氧化钙(Calcimol LC)的LCPCM与HCSC Biodentine的生物相容性。
制备每种材料的226个圆柱形标本(51.472毫米),并在无菌细胞培养基(α改良伊格尔培养基)中孵育24小时以获得提取物。将人牙髓细胞(hDPC)添加到标本和/或提取物中。检测细胞活力和细胞形态变化(MTT、LDH、活死染色、光学显微镜)。测定材料的钙释放量(钙比色法)和细胞的矿化能力(茜素红S染色、碱性磷酸酶测定)。采用方差分析和事后Tukey检验进行统计分析(p < 0.05)。
与Biodentine相比,hDPC与LCPCM接触时细胞活力显著降低(p < 0.05)。此外,在测试体周围观察到抑制区或细胞形态改变。Biodentine对细胞活力或细胞形态几乎没有负面影响。与Biodentine接触时,无论有无矿化诱导条件,hDPC都会矿化。在LCPCM中,仅在有诱导条件下,ReViCal和MTA PulpCap可检测到矿化。此外,Biodentine释放的钙离子明显多于LCPCM(p < 0.05)。
在这项体外研究中,LCPCM对hDPC显示出细胞毒性作用,几乎不能诱导细胞矿化。Biodentine对细胞活力几乎没有负面影响,能诱导细胞矿化,且比LCPCM释放更多的钙。在生物相容性和矿化诱导能力方面,Biodentine明显优于LCPCM。